504 related articles for article (PubMed ID: 22241171)
21. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
22. Cell membranes open "doors" for cationic nanoparticles/biomolecules: insights into uptake kinetics.
Lin J; Alexander-Katz A
ACS Nano; 2013 Dec; 7(12):10799-808. PubMed ID: 24251827
[TBL] [Abstract][Full Text] [Related]
23. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
25. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
26. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
Zhao Z; Wang X; Zhang Z; Zhang H; Liu H; Zhu X; Li H; Chi X; Yin Z; Gao J
ACS Nano; 2015 Mar; 9(3):2749-59. PubMed ID: 25688714
[TBL] [Abstract][Full Text] [Related]
27. Cellular translocation of a γ-AApeptide mimetic of Tat peptide.
Niu Y; Bai G; Wu H; Wang RE; Qiao Q; Padhee S; Buzzeo R; Cao C; Cai J
Mol Pharm; 2012 May; 9(5):1529-34. PubMed ID: 22413929
[TBL] [Abstract][Full Text] [Related]
28. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
29. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
Baoum A; Ovcharenko D; Berkland C
Int J Pharm; 2012 May; 427(1):134-42. PubMed ID: 21856394
[TBL] [Abstract][Full Text] [Related]
30. Biological effects of Tat cell-penetrating peptide: a multifunctional Trojan horse?
Lee D; Pacheco S; Liu M
Nanomedicine (Lond); 2014 Jan; 9(1):5-7. PubMed ID: 24354809
[No Abstract] [Full Text] [Related]
31. Cell-penetrating peptides as delivery vehicles for biology and medicine.
Stewart KM; Horton KL; Kelley SO
Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
[TBL] [Abstract][Full Text] [Related]
32. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
34. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
Fang B; Jiang L; Zhang M; Ren FZ
Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
[TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
[TBL] [Abstract][Full Text] [Related]
36. The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate.
Lin CW; Kuo JH; Jan MS
J Drug Target; 2012 Jul; 20(6):515-23. PubMed ID: 22632162
[TBL] [Abstract][Full Text] [Related]
37. Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity.
Wu X; Hu Z; Nizzero S; Zhang G; Ramirez MR; Shi C; Zhou J; Ferrari M; Shen H
J Control Release; 2017 Dec; 268():92-101. PubMed ID: 29042320
[TBL] [Abstract][Full Text] [Related]
38. Cell-penetrating peptides: design, synthesis, and applications.
Copolovici DM; Langel K; Eriste E; Langel Ü
ACS Nano; 2014 Mar; 8(3):1972-94. PubMed ID: 24559246
[TBL] [Abstract][Full Text] [Related]
39. Dual-pH Sensitive Charge-Reversal Polypeptide Micelles for Tumor-Triggered Targeting Uptake and Nuclear Drug Delivery.
Han SS; Li ZY; Zhu JY; Han K; Zeng ZY; Hong W; Li WX; Jia HZ; Liu Y; Zhuo RX; Zhang XZ
Small; 2015 Jun; 11(21):2543-54. PubMed ID: 25626995
[TBL] [Abstract][Full Text] [Related]
40. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]